Celldex Therapeutics, Inc. (CLDX)
32.50
+0.50
(+1.56%)
USD |
NASDAQ |
May 13, 16:00
32.50
0.00 (0.00%)
After-Hours: 16:24
Celldex Therapeutics Market Cap : 2.551B for May 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 39.35M |
| Perspective Therapeutics, Inc. | 436.80M |
| Myriad Genetics, Inc. | 352.29M |
| Atossa Therapeutics, Inc. | 44.69M |
| AVITA Medical, Inc. | 130.34M |
Market Cap Related Metrics
| PS Ratio | 2494.42 |
| PEG Ratio | -0.1310 |
| Price to Book Value | 5.592 |
| Price | 32.50 |
| Earnings Yield | -13.13% |
| PEGY Ratio | -0.1310 |